References: |
1. Kraker, A.J., et al. "Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma." Mol. Cancer Ther. 2:401-408 (2003). 2. Hubeek, I., et al. "CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo." Oncol. Rep. 19:1517-1523 (2008). 3. LoRusso, P.M., et al. "Preclinical antitumor activity of CI-994." Invest. New Drugs 14:349-356 (1996). 4. Loprevite, M., et al. "in vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines." Oncol. Res. 15:39-48 (2005). |